---
figid: PMC6959074__jcav11p1125g002
figtitle: nAChR-mediated signaling pathways that lead to lung cancer progression
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Nicotiana tabacum
pmcid: PMC6959074
filename: jcav11p1125g002.jpg
figlink: pmc/articles/PMC6959074/figure/F2/
number: F2
caption: 'nAChR-mediated signaling pathways that lead to lung cancer progression.
  Nicotine/α7nAChR mediates the proliferative effects through several pathways including
  PI3K/AKT, MEK/ERK, RAF1/Rb, and Sp1/GATA1 activation signaling in lung cancer cells.
  Cigarette smoking is associated with metastasis of lung cancer. Nicotine/α7nAChR
  can induce NSCLC cell migration and invasion via the MEK/ERK signaling pathway.
  NNK enhances lung cancer cell migration via activation of ERK or the Src-PKCiota-FAK
  signaling axis. Nicotine/α7nAChR can enhance the metastasis of lung cancer cells
  through activation of the YAP1-E2F1 signaling axis. Moreover, α7nAChR may facilitate
  lung cancer progression including angiogenesis via the PI3K/AKT or ERG1/FGF2 signaling
  pathways. α7nAChR-mediated signaling may be a potential target for attenuating the
  production of inflammatory cytokines in inflammatory cells. Nicotine/nAChR can promote
  lung cancer development via different signaling pathways. N: nicotine; NNK: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.'
papertitle: Nicotinic-nAChR signaling mediates drug resistance in lung cancer.
reftext: Wan-Li Cheng, et al. J Cancer. 2020;11(5):1125-1140.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9221442
figid_alias: PMC6959074__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
redirect_from: /figures/PMC6959074__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6959074__jcav11p1125g002.html
  '@type': Dataset
  description: 'nAChR-mediated signaling pathways that lead to lung cancer progression.
    Nicotine/α7nAChR mediates the proliferative effects through several pathways including
    PI3K/AKT, MEK/ERK, RAF1/Rb, and Sp1/GATA1 activation signaling in lung cancer
    cells. Cigarette smoking is associated with metastasis of lung cancer. Nicotine/α7nAChR
    can induce NSCLC cell migration and invasion via the MEK/ERK signaling pathway.
    NNK enhances lung cancer cell migration via activation of ERK or the Src-PKCiota-FAK
    signaling axis. Nicotine/α7nAChR can enhance the metastasis of lung cancer cells
    through activation of the YAP1-E2F1 signaling axis. Moreover, α7nAChR may facilitate
    lung cancer progression including angiogenesis via the PI3K/AKT or ERG1/FGF2 signaling
    pathways. α7nAChR-mediated signaling may be a potential target for attenuating
    the production of inflammatory cytokines in inflammatory cells. Nicotine/nAChR
    can promote lung cancer development via different signaling pathways. N: nicotine;
    NNK: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - CHRNA4
  - SRC
  - FGR
  - FYN
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RAF1
  - RNASE3
  - JAK2
  - PTK2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - NFKB1
  - STAT3
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - YAP1
  - E2F1
  - UBE2L3
  - NLRP3
  - EGR1
  - MYD88
  - SOX2
  - SP1
  - PSG1
  - DAND5
  - GATA1
  - FGF2
  - FGF13
  - Egf
  - Egfr
  - Chrnb1
  - Chrne
  - Src
  - Pik3cg
  - Raf1
  - Rnase2
  - Jak2
  - Ptk2
  - Ephb1
  - Nfkb1
  - Stat3
  - Creb1
  - Yap1
  - E2f1
  - Nlrp3
  - Egr1
  - Myd88
  - Sox2
  - Qsox1
  - Sp1
  - Gata1
  - Fgf2
  - Chrna7
  - Pik3r1
  - Ear1
  - Ephb2
  - Mapk1
  - Mdk
  - inflammation
  - cancer
---
